Table 6.

Net league table of ESRD progression.

ACEI	2.12 [0.73; 6.20]		1.08 [0.61; 1.91]	1.08 [0.85; 1.36]			1.27 [0.49; 3.27]
2.09 [0.72; 6.10]	ACEI + CCB	0.86 [0.43; 1.74]					0.61 [0.22; 1.70]
1.80 [0.50; 6.48]	0.86 [0.43; 1.74]	ACEI + TZD
1.14 [0.68; 1.89]	0.54 [0.17; 1.78]	0.63 [0.16; 2.50]	ARB	0.91 [0.52; 1.58]	0.95 [0.06; 15.31]	0.75 [0.25; 2.26]
1.08 [0.85; 1.36]	0.52 [0.17; 1.54]	0.60 [0.16; 2.20]	0.95 [0.57; 1.57]	ARB + ACEI
1.08 [0.06; 18.20]	0.52 [0.03; 10.60]	0.60 [0.03; 13.33]	0.95 [0.06; 15.31]	1.00 [0.06; 16.87]	ARB + CCB
0.86 [0.26; 2.87]	0.41 [0.08; 2.06]	0.48 [0.08; 2.77]	0.75 [0.25; 2.26]	0.79 [0.24; 2.66]	0.79 [0.04; 15.78]	ARB + RI
1.13 [0.49; 3.27]	0.61 [0.22; 1.67]	0.70 [0.20; 2.42]	1.12 [0.38; 3.28]	1.17 [0.44; 3.12]	1.17 [0.06; 23.15]	1.48 [0.32; 6.88]	CCB

ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blockers; CCB, calcium channel blockers; ESRD, end stage renal disease; RI, renin inhibitor; TZD, thiazide diuretics.